Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.

International journal of molecular sciences - 13 Mar 2024

Longo Vito, Catino Annamaria, Montrone Michele, Montagna Elisabetta Sara, Pesola Francesco, Marech Ilaria, Pizzutilo Pamela, Nardone Annalisa, Perrone Antonella, Gesualdo Monica, Galetta Domenico

Abstract excerpt

Recently, the fifth edition of the WHO classification recognized the thoracic SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) as a separate entity from conventional non-small cell lung cancer with SMARCA4 deficiency because of the different clinicopathological characteristics of these two diseases. SMARCA4-UT mainly occurs in young to middle-aged adults and involves a large mass compressing the tissues...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Helicases

Share to Lung Neoplasms

Share to Mutation

Share to Nuclear Proteins

Share to Sarcoma

Share to Transcription Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 38542211
DOI: 10.3390/ijms25063237
PMCID: PMC10970296

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.PMID 38542211Read ↗

[Clinical characteristics and prognostic analysis of thoracic SMARCA4-deficient undifferentiated tumor].Semantic proximity Read ↗

Clinicopathological characteristics and treatment outcomes of advanced SMARCA4-deficient thoracic tumors.Semantic proximity Read ↗

Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case SeriesSemantic proximity Read ↗

Thoracic SMARCA4-deficient undifferentiated tumorSemantic proximity Read ↗

Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4- deficent thoracic tumorsSemantic proximity Read ↗

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods.Semantic proximity Read ↗

CDK4/6 inhibition with dual immunotherapy in chemorefractory SMARCA4-deficient undifferentiated tumor: a case report.Semantic proximity Read ↗

[Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].Semantic proximity Read ↗

Defining the first bona fide cell model for SMARCA4-deficient, undifferentiated tumor.Semantic proximity Read ↗

SMARCA4-deficient undifferentiated tumor presenting with fever and polyarthralgia: A case reportSemantic proximity Read ↗

SMARCA4-Deficient Undifferentiated Esophageal Carcinoma: A Clinical Case Series and Literature ReviewSemantic proximity Read ↗

Intestinal SMARCA4-deficient undifferentiated carcinoma: a case series and systematic review of the literature.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.